Intec Pharma Ltd.
Rank 22
About
Using an Accordion Pill delivery system, Intec Pharma aims to improve the efficacy and safety of drug administration. The biopharmaceutical company is in the clinical stage of development, focusing on the use of cannabinoids THC and CBD to assist in the treatment of chronic and acute pain conditions. The company has facilities in the US and Israel.
$9.9000
USD
-12.48%
Market cap
$329,697,720
Total volume
$11,117,667
Shares outstanding
33,302,800
Rank 22
About
Using an Accordion Pill delivery system, Intec Pharma aims to improve the efficacy and safety of drug administration. The biopharmaceutical company is in the clinical stage of development, focusing on the use of cannabinoids THC and CBD to assist in the treatment of chronic and acute pain conditions. The company has facilities in the US and Israel.
Markets
| Exchange | Symbol | Volume (24h) | Volume (%) | Price |
|---|---|---|---|---|
|
|
NTEC |
$11,117,667
|
100% |
$9.9000
|
Chart